Literature DB >> 7970538

Postoperative intraocular pressure changes with use of different viscoelastics.

V K Dada1, N Sindhu, M S Sachdev.   

Abstract

Sixty eyes with age-related cataract underwent extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens (PC-IOL) implantation under similar conditions using hydroxypropyl methylcellulose (HPMC) (Oculose) (n = 20), sodium hyaluronate (Healon) (n = 20), or hyaluronic acid (IAL) (n = 20) as the viscoelastic (VE). Postoperative evaluation was performed for intraocular pressure (IOP), corneal thickness, and anterior chamber reaction at 6, 24, 48, 72 hours, and 10 days. Statistically-significant rises in IOP with IAL and Healon were observed at 6 and 24 hours; no such rises were observed with Oculose (P < .05). Seven eyes in the IAL group and six in the Healon group had IOPs greater than 22 mm Hg at 6 hours (range: 22 to 38 mm Hg and 22 to 28 mm Hg, respectively). A significant increase in average corneal thickness was observed in all of the 60 patients at 6 hours (18.5%). The average thickness decreased to 6.8% by day 10, with no intergroup variations. There were significantly fewer anterior chamber cells at 6 hours in the Healon group. We conclude that all three viscoelastics are equally useful for routine ECCE with PC-IOL implantation. However, IAL and Healon do cause an early postoperative IOP increase, which, though transient, should be treated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970538

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  2 in total

1.  Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents.

Authors:  G Rainer; R Menapace; O Findl; B Kiss; V Petternel; M Georgopoulos; B Schneider
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles.

Authors:  Yoo Chun Kim; Kyung Hee Oh; Henry F Edelhauser; Mark R Prausnitz
Journal:  Eur J Pharm Biopharm       Date:  2015-05-31       Impact factor: 5.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.